A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group study

Auteurs

O. Trédan, P. Follana, I. Moullet, C. Cropet, S. Trager-Maury, J. Dauba, S. Lavau-Denes, V. Diéras, D. Béal-Ardisson, M. Gouttebel, H. Orfeuvre, L. Stefani, C. Jouannaud, F. Bürki, T. Petit, E. Guardiola, C. Becuwe, E. Blot, E. Pujade-Lauraine, T. Bachelot